CytomX Therapeutics Inc [CTMX] Insider Activity: An Update for Investors

CytomX Therapeutics Inc’s filing revealed that its Chief Financial Officer Ogden Christopher unloaded Company’s shares for reported $28540.0 on Jun 16 ’25. In the deal valued at $2.69 per share,10,614 shares were sold. As a result of this transaction, Ogden Christopher now holds 226,271 shares worth roughly $0.54 million.

Then, Ogden Christopher sold 1,641 shares, generating $4,841 in total proceeds. Upon selling the shares at $2.95, the Chief Financial Officer now owns 199,385 shares.

Before that, BELVIN MARCIA sold 13,884 shares. CytomX Therapeutics Inc shares valued at $37,334 were divested by the SVP, Chief Scientific Officer at a price of $2.69 per share. As a result of the transaction, BELVIN MARCIA now holds 272,252 shares, worth roughly $0.65 million.

H.C. Wainwright upgraded its CytomX Therapeutics Inc [CTMX] rating to a Buy from a a Neutral in a research note published recently. Piper Sandler also remained covering CTMX and has increased its forecast on May 28, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. Wedbush revised its rating on May 09, 2024. It rated CTMX as “an Outperform” which previously was an “a Neutral”.

Price Performance Review of CTMX

On Tuesday, CytomX Therapeutics Inc [NASDAQ:CTMX] saw its stock jump 1.27% to $2.4. Over the last five days, the stock has gained 5.73%. CytomX Therapeutics Inc shares have risen nearly 84.62% since the year began. Nevertheless, the stocks have risen 133.01% over the past one year. While a 52-week high of $3.10 was reached on 06/13/25, a 52-week low of $0.40 was recorded on 04/07/25.

Levels Of Support And Resistance For CTMX Stock

The 24-hour chart illustrates a support level at 2.33, which if violated will result in even more drops to 2.26. On the upside, there is a resistance level at 2.48. A further resistance level may holdings at 2.55.

How much short interest is there in CytomX Therapeutics Inc?

A steep rise in short interest was recorded in CytomX Therapeutics Inc stocks on 2025-06-13, growing by 3.06 million shares to a total of 20.79 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 17.73 million shares. There was a rise of 14.73%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.